KPC Pharmaceuticals Inc. | Ownership
Companies that own KPC Pharmaceuticals Inc.
China Investment Corp. (Investment Management)
12,073,800
1.78%
0
0.04%
09/30/2017
PICC Asset Management Co., Ltd.
9,752,223
1.44%
-17,848,407
0.18%
09/30/2017
Harvest Fund Management Co., Ltd.
5,489,192
0.81%
-7,100
0.04%
12/31/2017
China Southern Asset Management Co., Ltd.
2,502,220
0.37%
-234,900
0.02%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,573,556
0.23%
25,000
0.1%
12/31/2017
HSBC Jintrust Management Co., Ltd.
1,293,232
0.19%
0
0.07%
12/31/2017
The Vanguard Group, Inc.
803,396
0.12%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
531,362
0.08%
-4,720
0.01%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
335,800
0.05%
303,500
0.04%
12/31/2017
SWS MU Fund Management Co., Ltd.
319,035
0.05%
-78,500
0.01%
12/31/2017
| Address |
No. 166 Keyi Road
Kunming Yunnan 650106
China
|
|
Employees
|
- |
| Website |
http://www.kpc.com.cn |
| Updated |
07/08/2019 |
| KPC Pharmaceuticals, Inc. engages in the research and development, manufacture, sale, commercial wholesale, and international marketing of drugs. It focuses on natural herbal-based Chinese medicine, chemical medicine, and pharmaceutical area. Its products include panax notoginseng, gastrodine, artemether, and special botanical drugs. |
